Assessment and Management of Myelosuppression in the Oncology Patient Online Course

This self-paced course utilizes a combination of didactic content, case studies and interactive learning activities to provide nurses with the information they need to provide evidence-based care to those at risk for or experiencing cancer-related myelosuppression.

Categories: Clinical Practice/Evidence-Based Practice, Palliative Care/EOL, Palliative Care/Hospice, Patient Population/Adult, Patient Population/Geriatric, Patient Population/Pediatric/Adolescent, Professional Issues/EBP, Symptom Management/Myelosuppression, Treatment/Chemotherapy/Biotherapy, Treatment/Radiation, Treatment/Surgery, Treatment/BMT/Stem Cell Transplant, Treatment/Clinical Trials, Treatment/CAM, Treatment/Targeted Therapies, Treatment/Pharmacology, Type of Cancer/Bladder Cancer, Type of Cancer/Brain Cancer, Type of Cancer/Breast Cancer, Type of Cancer/Colorectal Cancer, Type of Cancer/Gastrointestinal, Type of Cancer/Head and Neck Cancer, Type of Cancer/Hematology, Type of Cancer/HIV/AIDs, Type of Cancer/Lung Cancer, Type of Cancer/Pancreatic, Type of Cancer/Prostate Cancer, Type of Cancer/Renal, Type of Cancer/Reproductive Cancers, Type of Cancer/Sarcoma, Type of Cancer/Skin Cancer

FormatWebcourse
Contact Hours2.5
Member Price$49
Non-Member Price$69
Contacteducationcourses@ons.org
Technical RequirementsTechnical Requirements
Cancellation PolicyCancellation Policy

Upcoming Dates

No upcoming programs scheduled

Date Location Instructor Registration Deadline

Participate

ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

There is no sponsor for this webcourse.

ONCC Certification Test Blueprint Topics and ILNA Content Areas

Course Objectives

 
Define patients at risk for cancer related anemia, neutropenia, and thrombocytopenia.
Describe indicators used in the assessment of anemia, neutropenia, and thrombocytopenia in the cancer patient.
Identify appropriate interventions utilized in the management of anemia, neutropenia, and thrombocytopenia in the cancer patient.